Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006117HBVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS10006118HBVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS10050866HBVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS10045129HBVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS10045130HBVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS30088173HIVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS30033895HIVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS20067444HPVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS20031739HPVENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TVIS44028413HTLV-1ENSG00000136011.15protein_codingSTAB2NoNo55576Q8WWQ8
TCGA Plot Options
Drug Information
GeneSTAB2
DrugBank IDDB08818
Drug NameHyaluronic acid
Target IDBE0004948
UniProt IDQ8WWQ8
Regulation Typebinder
PubMed IDs11829752; 12626425; 17145755; 18434317
CitationsPolitz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Johansson S, Goerdt S: Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J. 2002 Feb 15;362(Pt 1):155-64.@@Zhou B, McGary CT, Weigel JA, Saxena A, Weigel PH: Purification and molecular identification of the human hyaluronan receptor for endocytosis. Glycobiology. 2003 May;13(5):339-49. Epub 2002 Dec 17.@@Harris EN, Kyosseva SV, Weigel JA, Weigel PH: Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J Biol Chem. 2007 Feb 2;282(5):2785-97. Epub 2006 Dec 4.@@Harris EN, Weigel JA, Weigel PH: The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J Biol Chem. 2008 Jun 20;283(25):17341-50. doi: 10.1074/jbc.M710360200. Epub 2008 Apr 22.
GroupsApproved; Vet_approved
Direct ClassificationAcylaminosugars
SMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Pathways
PharmGKBPA165958431
ChEMBL